The medical devices space is expected to witness strong growth beyond 2026, driven by increased investments in advanced AI-enabled technologies and connected health solutions. Vendors are actively optimizing portfolios through mergers, acquisitions, and spin-offs while prioritizing high-growth segments such as cardiovascular devices, clinical-grade wearables, and robotics. Companies are focusing on supply chain diversification and strengthening local manufacturing capabilities to better manage trade tariffs and global uncertainties. The healthcare delivery models are shifting, with notable growth in home care and ambulatory care settings aimed at reducing hospital burden. This transition is supported by the rising availability of enabling medical technologies. Vendors are also accelerating the development of non-invasive and minimally invasive solutions to expand care delivery beyond traditional hospital environments.

Explore megatrends that will redefine the future like the growth in ambulatory surgical center procedure volumes outpacing hospital procedure volumes, the growth of patient‑centric homecare due to expanding adoption of remote monitoring, wearables, and device connectivity, the evolution of AI as a built‑in, default component of medical devices, the focus of payers and providers on outcomes, the growth of minimally invasive procedures with strong support from digital surgery devices, the shift from fragmented solutions to integrated care platforms.

• Which growth avenues exist across key regions, including North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa?
• Why are key segments like patient monitoring devices, cardiovascular devices, wound care, respiratory solutions, neurology, robotics & navigation systems, clinical-grade wearables, diabetes care, minimally invasive surgery, orthopedics, audiology, and ophthalmology poised for growth?
• How can you gain intelligence on industry size, growth dynamics, emerging opportunities, strategic priorities, and macroeconomic factors influencing the medical device industry?